An Efficacy Study of Trabectedin in the Treatment of Participants With Specific Subtypes of Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: Dexamethasone|DRUG: Trabectedin
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators: PharmaMar